# N4 Pharma in very good shape as it moves forward (Interview)

- Link: https://www.directorstalkinterviews.com/n4-pharma-in-very-good-shape-as-it-moves-forward-interview/412859314
- Published: 2020-09-18T07:25:00+01:00
- Author: Giles Arbor

**N4 Pharma plc** (LON:N4P) CEO Nigel Theobald joins DirectorsTalk to discuss the
latest interim results. Nigel talks us through the highlights of the first half,
expands on a new refined strategy to focus on three clearly defined work streams,
how the Covid pandemic has presented opportunities for the business and what investors
can expect from N4 Pharma for the remainder of the year.

N4 Pharma is a specialist pharmaceutical company developing a novel delivery system
for cancer and vaccine treatments using its unique silica nanoparticle delivery 
system called Nuvec®.

The business model is to partner with companies developing novel antigens for cancer
and vaccine treatments to use Nuvec® as the delivery vehicle to get their antigen
into cells to express the protein needed for the required immunity. As these products
progress through pre clinical and clinical programs, N4 Pharma will seek to receive
up front payments, milestone payments and ultimately royalty payments once products
reach the market.

Share on: